Dr. Gilbert Tang is currently the Surgical Director of the Structural Heart Program at the Mount Sinai Health System and Professor in the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai in New York. He has >10 years of experience in treating structural heart disease and performed over 3000 cases of transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (MitraClip), transcatheter mitral valve replacement, and tricuspid valve repair and replacement procedures. He obtained his BA from Harvard University and MD from University of Toronto. Dr. Tang completed his residency training at the University of Toronto and also a Masters of Science there and an MBA at Harvard. Dr. Tang is leading a number of multicenter studies in structural heart disease, including the global EXPLANT-TAVR, EXPLANTORREDO-TAVR, and CUTTING-EDGE registries. He pioneered the cusp-overlap technique to optimize self-expanding TAVR deployment and commissural alignment technique to help better orient TAVR devices (the ALIGN-TAVR study). He serves on multiple committees in the Heart Valve Collaboratory and PCR. Dr Tang’s research has been published in many top peer-reviewed medical journals and presented at many international conferences. He is a 2-time recipient of the Top Reviewer Award for Eurointervention and the Simon Dack Award for Outstanding Scholarship for the Journal of American College of Cardiology, and is recently selected as an Associate Editor in Circulation: Cardiovascular Interventions. He has trained many physicians and heart teams to perform transcatheter valve procedures around the world. Dr. Tang is a member of the AATS, STS, AHA and a Fellow of the Royal College of Surgeons of Canada (FRCSC), American College of Cardiology (FACC) and Society for Cardiovascular Angiography and Interventions (FSCAI).
General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Abbott Vascular(SIGNIFICANT), Medtronic(SIGNIFICANT), NeoChord(NONE), JenaValve(NONE)